JiangXi Tianxin Pharm Co Ltd Capital Reinvestment Ratio
JiangXi Tianxin Pharm Co Ltd capital reinvestment ratio. JiangXi Tianxin Pharm Co Ltd (603235) has a Capital Reinvestment Ratio of 0.92x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥629.36 Million) in capital expenditures (CN¥580.68 Million). Check JiangXi Tianxin Pharm Co Ltd (603235) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of JiangXi Tianxin Pharm Co Ltd (2020–2025)
Capital reinvestment ratio of JiangXi Tianxin Pharm Co Ltd from 2020 to 2025. This chart tracks JiangXi Tianxin Pharm Co Ltd's Capital Reinvestment Ratio across 6 annual periods. Also explore JiangXi Tianxin Pharm Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
JiangXi Tianxin Pharm Co Ltd Capital Reinvestment Ratio by Year (2020–2025)
JiangXi Tianxin Pharm Co Ltd capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see 603235 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | CN¥629.36 Million | CN¥580.68 Million | ▼ -56.8% |
| 2024 | 2.14x | CN¥499.66 Million | CN¥1.07 Billion | ▲ +190.7% |
| 2023 | 0.73x | CN¥729.21 Million | CN¥535.60 Million | ▲ +71.0% |
| 2022 | 0.43x | CN¥606.61 Million | CN¥260.50 Million | ▲ +63.1% |
| 2021 | 0.26x | CN¥818.63 Million | CN¥215.50 Million | ▲ +1.1% |
| 2020 | 0.26x | CN¥1.16 Billion | CN¥303.04 Million | — |